High-Throughput Isolation of Extracellular Vesicles for Next-Generation Diagnostic Assays
Extracellular vesicles (EVs) have been shown to serve as disease biomarkers in liquid biopsies due to their unique phenotype and high frequency in biofluids. As such, it is critical to employ effective EV isolation methods during the pre-analytical phase so that you maximize the quality and quantity of information conveyed by the assay. In this webinar, Dr. Coral-Ann Lewis discusses opportunities to potentiate the clinical validation of EVs as diagnostic biomarkers, as well as available technologies to isolate them prior to downstream testing.
Publish Date:
November 14, 2023
Request Pricing
Thank you for your interest in this product. Please provide us with your contact information and your local representative will contact you with a customized quote. Where appropriate, they can also assist you with a(n):
Estimated delivery time for your area
Product sample or exclusive offer
In-lab demonstration
By submitting this form, you are providing your consent to STEMCELL Technologies Canada Inc. and its subsidiaries and affiliates (“STEMCELL”) to collect and use your information, and send you newsletters and emails in accordance with our privacy policy. Please contact us with any questions that you may have. You can unsubscribe or change your email preferences at any time.